ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$165.04
Tradestie Score
60
Market Cap
$60.38B
P/E Ratio
7.9
Revenue Growth
0.2%
Analyst Upside
+81.8%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$121.16
|
$31.13B | - | 41 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.60
|
$24.57B | - | 52 | Compare |
|
GMAB
Genmab A/S ADS
|
$51.37
|
$19.56B | 44.2 | 35 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.97
|
$16.93B | 62.1 | 58 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$69.31
|
$15.70B | 45.1 | 47 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.15
|
$15.22B | - | 46 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$167.40
|
$13.59B | 25.1 | 30 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$275.39
|
$12.36B | 18.2 | 39 | Compare |
|
EXEL
Exelixis Inc
|
$69.00
|
$11.09B | 20.9 | 36 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$39.53
|
$10.76B | - | 39 | Compare |
More ALNY Analysis
Data updated: Nov 14, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry